PGP and chronic kidney disease: Additionally, IS increased the expression and activity of hepatocellular efflux transport protein P-glycoprotein (P-gp) during CKD by activating AhR, thus promoting the clearance of cyclosporine, a P-gp substrate, from the liver [43].